Literature DB >> 27610652

Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking.

Gina-Eva Görtz1, Mareike Horstmann1, Barbara Aniol1, Buena Delos Reyes1, Joachim Fandrey1, Anja Eckstein1, Utta Berchner-Pfannschmidt1.   

Abstract

CONTEXT: In Graves' ophthalmopathy (GO), inflammation with tissue expansion in a closed compartment like the bony orbit and smoking may cause tissue hypoxia.
OBJECTIVES: In this study, we investigated whether hypoxia-inducible factor-1 (HIF-1) action impacts on tissue remodeling in GO with the aim to identify possible new therapeutic targets. DESIGN/SETTING/PARTICIPANTS: Orbital fibroblasts (OFs) were derived from GO patients and control (Ctrl) persons. We analyzed HIF-1α levels in response to hypoxia and cigarette smoke extract, as well as HIF-1-dependent vascular endothelial growth factor (VEGF) release and adipogenic differentiation, by using HIF-1α small interfering RNA, or HIF-1 inhibitor BAY 87-2243. MAIN OUTCOME MEASURES: Western blot, real-time PCR, ELISA, and immunohistochemistry were used to analyze HIF-1α, VEGF, CD31, and adiponectin. Adipogenic differentiation was measured with Nile red assay.
RESULTS: Higher HIF-1α levels in OFs were correlated with the clinical activity score of GO patients. Cigarette smoke extract elevated HIF-1α levels. HIF-1-dependent VEGF secretion was enhanced in GO-OF compared to Ctrl-OF, and as an in vivo consequence, we found a higher vessel density in GO tissue than in Ctrl tissue. Hypoxia strongly stimulated HIF-1-dependent adipogenesis and adiponectin release of GO-OF and enhanced TSH receptor-mediated adipogenesis.
CONCLUSIONS: Hypoxia impacts on tissue remodeling in GO by stimulating angiogenesis and adipogenesis through activation of HIF-1-dependent pathways in OFs. Our results offer a molecular mechanism for the detrimental influence of smoking on GO and an explanation as to why decompression can improve the outcome of patients. Drug-targeted inhibition of HIF-1/VEGF may provide a therapeutic option to control tissue expansion in GO.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27610652     DOI: 10.1210/jc.2016-1279

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

Review 2.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

Review 3.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

Review 4.  Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review.

Authors:  Xueting Li; Senmao Li; Wanlin Fan; Alexander C Rokohl; Sitong Ju; Xiaojun Ju; Yongwei Guo; Ludwig M Heindl
Journal:  Int Ophthalmol       Date:  2022-10-22       Impact factor: 2.029

5.  A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.

Authors:  Stephanie Hiu Ling Poon; Janice Jing-Chee Cheung; Kendrick Co Shih; Yau Kei Chan
Journal:  Rev Endocr Metab Disord       Date:  2022-01-23       Impact factor: 6.514

6.  The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response.

Authors:  Yong-Jiang Li; Yong Luo; Xiao-Qi Xie; Wei-Min He; Cheng Yi; Ping Li; Feng Wang
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

Review 7.  Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface.

Authors:  Priscila Novaes; Ana Beatriz Diniz Grisolia; Terry J Smith
Journal:  Clin Diabetes Endocrinol       Date:  2016-11-16

8.  A novel physiological role for cardiac myoglobin in lipid metabolism.

Authors:  Ulrike B Hendgen-Cotta; Sonja Esfeld; Cristina Coman; Robert Ahrends; Ludger Klein-Hitpass; Ulrich Flögel; Tienush Rassaf; Matthias Totzeck
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

9.  The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts.

Authors:  Elisa Roztocil; Christine L Hammond; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

10.  SNP rs12982687 affects binding capacity of lncRNA UCA1 with miR-873-5p: involvement in smoking-triggered colorectal cancer progression.

Authors:  Yang Fu; Yizheng Zhang; Jinyuan Cui; Ge Yang; Sanfei Peng; Wunan Mi; Xiangya Yin; Yang Yu; Jianwu Jiang; Qi Liu; Yiyu Qin; Wen Xu
Journal:  Cell Commun Signal       Date:  2020-03-06       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.